These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 27614953)

  • 1. Epidemiology and Early Detection of Cervical Cancer.
    Hillemanns P; Soergel P; Hertel H; Jentschke M
    Oncol Res Treat; 2016; 39(9):501-6. PubMed ID: 27614953
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence regarding human papillomavirus testing in secondary prevention of cervical cancer.
    Arbyn M; Ronco G; Anttila A; Meijer CJ; Poljak M; Ogilvie G; Koliopoulos G; Naucler P; Sankaranarayanan R; Peto J
    Vaccine; 2012 Nov; 30 Suppl 5():F88-99. PubMed ID: 23199969
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interpretation of p16(INK4a) /Ki-67 dual immunostaining for the triage of human papillomavirus-positive women by experts and nonexperts in cervical cytology.
    Allia E; Ronco G; Coccia A; Luparia P; Macrì L; Fiorito C; Maletta F; Deambrogio C; Tunesi S; De Marco L; Gillio-Tos A; Sapino A; Ghiringhello B
    Cancer Cytopathol; 2015 Apr; 123(4):212-8. PubMed ID: 25534957
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HPV testing and vaccination in Europe.
    Leeson SC; Alibegashvili T; Arbyn M; Bergeron C; Carriero C; Mergui JL; Nieminen P; Prendiville W; Redman CW; Rieck GC; Quaas J; Petry KU
    J Low Genit Tract Dis; 2014 Jan; 18(1):61-9. PubMed ID: 23774078
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Self-collection of vaginal specimens for human papillomavirus testing in cervical cancer prevention (MARCH): a community-based randomised controlled trial.
    Lazcano-Ponce E; Lorincz AT; Cruz-Valdez A; Salmerón J; Uribe P; Velasco-Mondragón E; Nevarez PH; Acosta RD; Hernández-Avila M
    Lancet; 2011 Nov; 378(9806):1868-73. PubMed ID: 22051739
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Screening for cervical cancer: U.S. Preventive Services Task Force recommendation statement.
    Moyer VA;
    Ann Intern Med; 2012 Jun; 156(12):880-91, W312. PubMed ID: 22711081
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overview of human papillomavirus-based and other novel options for cervical cancer screening in developed and developing countries.
    Cuzick J; Arbyn M; Sankaranarayanan R; Tsu V; Ronco G; Mayrand MH; Dillner J; Meijer CJ
    Vaccine; 2008 Aug; 26 Suppl 10():K29-41. PubMed ID: 18847555
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human papillomavirus testing in young women: clinical outcomes of human papillomavirus triage in a UK cervical screening program.
    McKenna M; McMenamin MM
    Cancer Cytopathol; 2014 Sep; 122(9):702-10. PubMed ID: 24888573
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cervical cancer screening in sub-Saharan Africa: a randomized trial of VIA versus cytology for triage of HPV-positive women.
    Bigoni J; Gundar M; Tebeu PM; Bongoe A; Schäfer S; Fokom-Domgue J; Catarino R; Tincho EF; Bougel S; Vassilakos P; Petignat P
    Int J Cancer; 2015 Jul; 137(1):127-34. PubMed ID: 25420434
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Early detection of cervical cancer in Germany: evidence and implementation].
    Seifert U; Klug SJ
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2014 Mar; 57(3):294-301. PubMed ID: 24562703
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Study on the value assessment of various screening programs regarding cervical cancer screening strategy in the rural areas of China].
    Li LY; Qiao ZQ; Zhang MF; Yang JP; Bao YP; An YT; Lei J; Xiong NH; Yu XH; Zhang X; Pan QJ; Qiao YL
    Zhonghua Liu Xing Bing Xue Za Zhi; 2007 Oct; 28(10):964-7. PubMed ID: 18399140
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increasing participation in cervical cancer screening: offering a HPV self-test to long-term non-attendees as part of RACOMIP, a Swedish randomized controlled trial.
    Broberg G; Gyrd-Hansen D; Miao Jonasson J; Ryd ML; Holtenman M; Milsom I; Strander B
    Int J Cancer; 2014 May; 134(9):2223-30. PubMed ID: 24127304
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cervical Cancer Screening: What's New? Updates for the Busy Clinician.
    Zhang S; McNamara M; Batur P
    Am J Med; 2018 Jun; 131(6):702.e1-702.e5. PubMed ID: 29408216
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention of Cervical Cancer: Guideline of the DGGG and the DKG (S3 Level, AWMF Register Number 015/027OL, December 2017) - Part 2 on Triage, Treatment and Follow-up.
    Hillemanns P; Friese K; Dannecker C; Klug S; Seifert U; Iftner T; Hädicke J; Löning T; Horn L; Schmidt D; Ikenberg H; Steiner M; Freitag U; Siebert U; Sroczynski G; Sauerbrei W; Beckmann MW; Gebhardt M; Friedrich M; Münstedt K; Schneider A; Kaufmann A; Petry KU; Schäfer APA; Pawlita M; Weis J; Mehnert A; Fehr M; Grimm C; Reich O; Arbyn M; Kleijnen J; Wesselmann S; Nothacker M; Follmann M; Langer T; Jentschke M
    Geburtshilfe Frauenheilkd; 2019 Feb; 79(2):160-176. PubMed ID: 30792546
    [No Abstract]   [Full Text] [Related]  

  • 15. Prevention of Cervical Cancer: Guideline of the DGGG and the DKG (S3 Level, AWMF Register Number 015/027OL, December 2017) - Part 1 with Introduction, Screening and the Pathology of Cervical Dysplasia.
    Hillemanns P; Friese K; Dannecker C; Klug S; Seifert U; Iftner T; Hädicke J; Löning T; Horn L; Schmidt D; Ikenberg H; Steiner M; Freitag U; Siebert U; Sroczynski G; Sauerbrei W; Beckmann MW; Gebhardt M; Friedrich M; Münstedt K; Schneider A; Kaufmann A; Petry KU; Schäfer APA; Pawlita M; Weis J; Mehnert A; Fehr M; Grimm C; Reich O; Arbyn M; Kleijnen J; Wesselmann S; Nothacker M; Follmann M; Langer T; Jentschke M
    Geburtshilfe Frauenheilkd; 2019 Feb; 79(2):148-159. PubMed ID: 30792545
    [No Abstract]   [Full Text] [Related]  

  • 16. [WHO Guideline for Screening and Treatment of Cervical Pre-Cancerous Lesions for Cervical Cancer Prevention (Second Edition)].
    Harlfinger J; Sommer I; Gartlehner G
    Gesundheitswesen; 2023 Jul; 85(7):630-634. PubMed ID: 37437562
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Changes to cervical cancer screening in Germany].
    Starrach T; Gallwas J; Blankenstein T; Mahner S; Dannecker C
    MMW Fortschr Med; 2018 Feb; 160(2):46-51. PubMed ID: 29417509
    [No Abstract]   [Full Text] [Related]  

  • 18. An emerging paradigms on cervical cancer screening methods and devices for clinical trails.
    Raimond K; Rao GB; Juliet S; Tamilarasi SRG; Evangelin PS; Mathew L
    Front Public Health; 2022; 10():1030304. PubMed ID: 36388384
    [No Abstract]   [Full Text] [Related]  

  • 19. A Change of Paradigm in the Treatment of Cervical Cancer.
    Mallmann P
    Oncol Res Treat; 2016; 39(9):500. PubMed ID: 27614447
    [No Abstract]   [Full Text] [Related]  

  • 20. First cervical cancer vaccine--from pipe dream to pipeline.
    Indian J Med Sci; 1999 Oct; 53(10):454-5. PubMed ID: 10776503
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.